[1]
“Safety and effectiveness of docetaxel combinated with S-1 for patients with incurable recurrent squamous cell carcinoma of the head and neck”, Eur J Oncol, vol. 20, no. 3/4, pp. 174–179, Dec. 2015, Accessed: Jul. 01, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4294